Aging and efficacy of disease-modifying therapies in multiple sclerosis: A meta-analysis of clinical trials
Therapeutic Advances in Neurological Disorders
Open Access Publication
Rights and Permissions
Zhang Y, Gonzalez Caldito N, Shirani A, Salter A, Cutter G, Culpepper W 2nd, Wallin M, Kosa P, Bielekova B, Lublin F, Stuve O. Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. Ther Adv Neurol Disord. 2020 Oct 28;13:1756286420969016. doi: 10.1177/1756286420969016. © The Author(s), 2020. Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages https://us.sagepub.com/en-us/nam/open-access-at-sage).
Zhang, Yinan; Gonzalez Caldito, Natalia; Shirani, Afsaneh; Salter, Amber; Cutter, Gary; Culpepper, William; Wallin, Mitchell; Kosa, Peter; Bielekova, Bibiana; Lublin, Fred; and Stuve, Olaf, "Aging and efficacy of disease-modifying therapies in multiple sclerosis: A meta-analysis of clinical trials." Therapeutic Advances in Neurological Disorders. 13, 1756286420969016 (2020).